TOMM40L and Parkinson disease: Therefore, we speculate that the infectious agent TMV can be a driver of molecular mimicry, eliciting anti-TMV antibodies cross-reacting with TOMM40L protein to alter the host’s mitochondrial function; in smokers, anti-TMV antibodies may modulate the acquired mitochondrial defects through molecular mimicry to prevent PD development.